Clinical Trials

223 enrolled 14 charts

Prostatic Neoplasms

NCT01616875 2026-03-06

Bristol Bladder Trial

28 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02703623 2026-03-06

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

196 enrolled

Prostatic Neoplasms

NCT06632977 2026-03-04

PREDICT

474 enrolled

Prostatic Neoplasms

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

96 enrolled

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

14 enrolled 16 charts

Prostatic Neoplasms

NCT04592237 2025-12-23

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

120 enrolled

Prostatic Neoplasms

NCT02985957 2025-12-22

CheckMate 650

351 enrolled 43 charts

Prostatic Neoplasms

NCT04709276 2025-09-11

CHAMP

41 enrolled

Prostatic Neoplasms

NCT06738303 2025-08-27

CATCH-177

44 enrolled

Prostatic Neoplasms

NCT05005728 2025-07-17

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

72 enrolled

Prostatic Neoplasms

NCT03764540 2025-04-13

CABPOSTAAT

57 enrolled

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06890832 2025-03-24

A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

75 enrolled

Metastatic Castration-resistant Prostate Cancer, MCRPC

NCT02218606 2024-12-10

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

81 enrolled 11 charts

Prostatic Neoplasms

NCT05762536 2024-06-27

DAROTAXEL

245 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT05563558 2024-06-11

PEAPOD_FOS

42 enrolled

Prostate Cancer Metastatic

NCT03934840 2024-02-28

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

22 enrolled

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

40 enrolled 18 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT02543255 2024-01-31

ACDC-RP

76 enrolled

Prostatic Neoplasms

NCT04495179 2023-08-09

AARDVARC

30 enrolled 22 charts

Prostatic Neoplasms

NCT03114254 2022-11-18

JAVA-P

17 enrolled

Neoplasm Metastasis, Penile Neoplasms, Recurrence

NCT03392428 2022-06-13

TheraP

201 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT01650285 2022-03-04

Cabazitaxel and Radiation For Patients With Prostate Cancer

5 enrolled 5 charts

Prostatic Neoplasms

NCT03101046 2022-02-10

TACTIK

40 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03050866 2021-08-20

CABA-V7

Phase 2 Unknown

140 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02844582 2021-01-25

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

2 enrolled 5 charts

Phase 2 Not yet recruiting

Hormone-Resistant Prostate Cancer

NCT04622761 2021-01-05

CHROME

120 enrolled

Prostatic Neoplasms

NCT02512458 2020-02-10

CABA-BONE

60 enrolled

Bone Metastatic Prostate Cancer

NCT02379390 2019-06-21

PRIMCAB

8 enrolled 8 charts

Prostate Cancer Metastatic

NCT01845792 2018-06-04

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

7 enrolled 10 charts

Prostatic Neoplasms

NCT03356912 2017-12-14

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Phase 2 Unknown

220 enrolled

Prostatic Neoplasms

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

120 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT01718353 2017-11-20

TAXYNERGY

63 enrolled 13 charts

Prostate Cancer Metastatic

NCT02621190 2016-08-17

CARVE

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01541007 2015-11-02

ConCab

100 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

19 enrolled

Carcinoma, Transitional Cell

NCT01469338 2014-11-24

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

9 enrolled

Diarrhea, Prostatic Neoplasms

NCT01531205 2014-11-05

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

2 enrolled 6 charts

Prostatic Neoplasms, Recurrence

NCT01576029 2013-12-24

SWITCH

2 enrolled

Prostatic Neoplasms

NCT01750866 2013-10-16

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Phase 2 Withdrawn